Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare    

Pharmaceuticals Market

PRODUCT TITLE PUBLISHED
Nivolumab Nivolumab
Nivolumab and Chromatography, E-Clinical Trial...
Upcoming
Hyper-CVAD regimen Hyper-CVAD regimen
Hyper-CVAD regimen and CALGB 8811 regimen, Linker Regimen,
Upcoming
CALGB 8811 regimen CALGB 8811 regimen
CALGB 8811 regimen and Hyper-CVAD regimen, Linker Regimen,
Upcoming
Linker Regimen Linker Regimen
Linker Regimen and Hyper-CVAD regimen, CALGB 8811 regimen,...
Upcoming
Nucleoside Metabolic Inhibitors (Clolar + Nelarabine) Nucleoside Metabolic Inhibitors (Clolar + Nelarabine)
Nucleoside Metabolic Inhibitors (Clolar + Nelarabine) and Hyper-CVAD regimen,
Upcoming
Oncaspar (Pegaspargase) Oncaspar (Pegaspargase)
Oncaspar (Pegaspargase) and Hyper-CVAD regimen, CALGB 8811...
Upcoming
Daunorubicin + Cytarabine (For Induction) Daunorubicin + Cytarabine (For Induction)
Daunorubicin + Cytarabine (For Induction) and Graspa, Cytarabine (For...
Upcoming
Cytarabine (For Relapse) Cytarabine (For Relapse)
Cytarabine (For Relapse) and Graspa, Daunorubicin +...
Upcoming
Daunorubicin + Cytarabine (For Elderly) Daunorubicin + Cytarabine (For Elderly)
Daunorubicin + Cytarabine (For Elderly) and Graspa,
Upcoming
VCD Regimen (APL) VCD Regimen (APL)
VCD Regimen (APL) and Graspa, Daunorubicin + Cytarabine...
Upcoming
AVD Regimen (APL) AVD Regimen (APL)
AVD Regimen (APL) and Graspa, Daunorubicin + Cytarabine...
Upcoming
Campath/MabCampath Campath/MabCampath
Campath/MabCampath and Treanda, Arzerra,
Upcoming
Treanda Treanda
Treanda and Campath/MabCampath, Arzerra,
Upcoming
Fludara Fludara
Fludara and Campath/MabCampath, Treanda,
Upcoming
FCR Regimen FCR Regimen
FCR Regimen and Campath/MabCampath, Treanda,
Upcoming
FC Regimen FC Regimen
FC Regimen and Campath/MabCampath, Treanda,
Upcoming
Bosutinib Bosutinib
Bosutinib and Lab-on-chips (Microfluidics),
Upcoming
Gleevec Gleevec
Gleevec and Lab-on-chips (Microfluidics), Microreactors,...
Upcoming
Sprycel Sprycel
Sprycel and Lab-on-chips (Microfluidics), Microreactors,...
Upcoming
Phase II Phase II
Phase II and Phase I and Phase III adds up to total Pipeline Drugs market. ...
Upcoming
812 reports | Show
Connect With Us
US/CAN : +1-888-502-0539